Charles L. Campbell

2.7k total citations · 1 hit paper
21 papers, 1.7k citations indexed

About

Charles L. Campbell is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Pharmacology. According to data from OpenAlex, Charles L. Campbell has authored 21 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 8 papers in Internal Medicine and 3 papers in Pharmacology. Recurrent topics in Charles L. Campbell's work include Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Acute Myocardial Infarction Research (5 papers). Charles L. Campbell is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Acute Myocardial Infarction Research (5 papers). Charles L. Campbell collaborates with scholars based in United States and France. Charles L. Campbell's co-authors include Steven R. Steinhubl, Fredric J. Pashkow, Susan S. Smyth, Robert E. Eckart, Gilles Montalescot, Robert N. Potter, Stephanie L. Scoville, Karl C. Stajduhar, Eric A. Shry and Lisa Pearse and has published in prestigious journals such as JAMA, Circulation and Annals of Internal Medicine.

In The Last Decade

Charles L. Campbell

21 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits

2004 593 citations Robert E. Eckart, Stephanie L. Scoville et al. Annals of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles L. Campbell United States	12	925	384	312	228	219	21	1.7k
Yukihiko Momiyama Japan	26	647 0.7×	417 1.1×	340 1.1×	399 1.8×	165 0.8×	106	2.1k
Ahmet Menteşe Türkiye	28	325 0.4×	515 1.3×	327 1.0×	588 2.6×	145 0.7×	159	2.5k
Marie E. Steiner United States	27	311 0.3×	737 1.9×	537 1.7×	330 1.4×	721 3.3×	122	2.9k
Jan Eritsland Norway	27	826 0.9×	415 1.1×	134 0.4×	243 1.1×	73 0.3×	81	2.0k
Petra Jilma‐Stohlawetz Austria	24	402 0.4×	240 0.6×	85 0.3×	240 1.1×	327 1.5×	53	1.9k
Gaetano Tanzilli Italy	24	1.1k 1.1×	407 1.1×	225 0.7×	198 0.9×	28 0.1×	108	1.7k
Philip C. Comp United States	20	1.4k 1.6×	664 1.7×	264 0.8×	157 0.7×	186 0.8×	48	2.9k
A Barsotti Italy	15	491 0.5×	240 0.6×	141 0.5×	164 0.7×	61 0.3×	59	1.2k
Massimo R. Mannarino Italy	31	873 0.9×	648 1.7×	262 0.8×	458 2.0×	67 0.3×	77	2.6k
Wook‐Jin Chung South Korea	23	846 0.9×	537 1.4×	329 1.1×	339 1.5×	39 0.2×	122	2.1k

Countries citing papers authored by Charles L. Campbell

Since Specialization

Citations

This map shows the geographic impact of Charles L. Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles L. Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles L. Campbell more than expected).

Fields of papers citing papers by Charles L. Campbell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles L. Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles L. Campbell. The network helps show where Charles L. Campbell may publish in the future.

Co-authorship network of co-authors of Charles L. Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Charles L. Campbell. A scholar is included among the top collaborators of Charles L. Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles L. Campbell. Charles L. Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Campbell, Charles L., et al.. (2019). Prognostic Role of Elevated Myeloperoxidase in Patients with Acute Coronary Syndrome: A Systemic Review and Meta-Analysis. Mediators of Inflammation. 2019. 1–9. 20 indexed citations

Kim, Sun Moon, Charles L. Campbell, Richard Charnigo, et al.. (2017). QT prolongation is associated with increased mortality in end stage liver disease. World Journal of Cardiology. 9(4). 347–347. 32 indexed citations

McRae, Michael P., Biykem Bozkurt, Christie M. Ballantyne, et al.. (2016). Cardiac ScoreCard: A diagnostic multivariate index assay system for predicting a spectrum of cardiovascular disease. Expert Systems with Applications. 54. 136–147. 29 indexed citations

Dekker, Rebecca L., Lynn V. Doering, Alison Bailey, et al.. (2014). Abstract 13961: A Single Cognitive Behavior Therapy Session Improves Short-Term Depressive Symptoms in Hospitalized Patients with Heart Failure. Circulation. 130. 3 indexed citations

Campbell, Charles L., et al.. (2014). Serum biomarker release patterns following alcohol septal ablation for treatment of hypertrophic cardiomyopathy. 161–161. 2 indexed citations

Wallace, Eric, John Kotter, Richard Charnigo, et al.. (2013). Fibrinolytic Therapy Versus Primary Percutaneous Coronary Interventions for ST-Segment Elevation Myocardial Infarction in Kentucky. Southern Medical Journal. 106(7). 391–398. 1 indexed citations

Whitbeck, Matthew G., Richard Charnigo, Brandon K. Fornwalt, et al.. (2012). INCREASED MORBIDITY AND MORTALITY AMONG ATRIAL FIBRILLATION PATIENTS WITH PROLONGED QRS: RESULTS FROM THE AFFIRM STUDY. Journal of the American College of Cardiology. 59(13). E618–E618. 1 indexed citations

Bailey, Alison & Charles L. Campbell. (2011). Oral Antiplatelet Therapy for Acute Coronary Syndromes: Aspirin, P2Y12 Inhibition and Thrombin Receptor Antagonists. Current Drug Targets. 12(12). 1805–1812. 3 indexed citations

Selim, Samy, Manjula Sunkara, Steve Leung, et al.. (2011). Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions. Clinical Science. 121(12). 565–572. 53 indexed citations

10.

Campbell, Charles L., Steven R. Steinhubl, W. Craig Hooper, et al.. (2010). Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy. Journal of Thrombosis and Thrombolysis. 31(2). 139–145. 22 indexed citations

11.

Oestreich, Julie H., Steven P. Dunn, Susan S. Smyth, et al.. (2009). Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose of clopidogrel. Coronary Artery Disease. 20(3). 207–213. 11 indexed citations

12.

Pashkow, Fredric J., et al.. (2008). Astaxanthin: A Novel Potential Treatment for Oxidative Stress and Inflammation in Cardiovascular Disease. The American Journal of Cardiology. 101(10). S58–S68. 343 indexed citations

13.

Campbell, Charles L., Susan S. Smyth, Gilles Montalescot, & Steven R. Steinhubl. (2007). Aspirin Dose for the Prevention of Cardiovascular Disease. JAMA. 297(18). 2018–2018. 302 indexed citations

14.

Campbell, Charles L.. (2006). New treatment options for acute coronary syndromes.. PubMed. 12(16 Suppl). S435–43. 6 indexed citations

15.

Campbell, Charles L., Peter B. Berger, James L. Orford, et al.. (2005). Can N-acetylcysteine reverse the antiplatelet effects of clopidogrel? An in vivo and vitro study. American Heart Journal. 150(4). 796–799. 6 indexed citations

16.

Campbell, Charles L. & Steven R. Steinhubl. (2005). Variability in response to aspirin: do we understand the clinical relevance?. Journal of Thrombosis and Haemostasis. 3(4). 665–669. 55 indexed citations

17.

Eckart, Robert E., J. Edwin Atwood, Mark K Arness, et al.. (2004). Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination11The views expressed in this study are those of the authors and do not reflect the official policy or position of the U.S. government.. Journal of the American College of Cardiology. 44(1). 201–205. 124 indexed citations

18.

Campbell, Charles L., et al.. (2004). Point-of-Care Determination of Baseline Platelet Function as a Predictor of Clinical Outcomes in Patients who Present to the Emergency Department with Chest Pain. Journal of Thrombosis and Thrombolysis. 18(2). 109–115. 3 indexed citations

19.

Campbell, Charles L., Eric J. Topol, & Steven R. Steinhubl. (2004). The Clinical Implications of Detecting Aspirin Resistance. US Cardiology Review. 1(1). 39–42. 2 indexed citations

20.

Eckart, Robert E., Stephanie L. Scoville, Charles L. Campbell, et al.. (2004). Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits. Annals of Internal Medicine. 141(11). 829–834. 593 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact